Douglas DiRuggiero, DMSc, PA-C: Benefits of Oral JAK Inhibitors for Atopic Dermatitis

Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.


Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in rosacea pathogenesis and treatment. ...